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Abstract.  Glycolipid transport between compartments 
of the Golgi apparatus  has been reconstituted in a cell 
free system. Transport  of lactosylceramide (galactose 
B1-4-glucose-ceramide) was followed from a donor to 
an acceptor Golgi population.  The major glycolipid in 
CHO cells is GM3 (sialic acid ot2-3 galactose/~l-4-glu- 
cose-ceramide).  Donor membranes were derived from 
a  Chinese hamster ovary (CHO) cell mutant (Lec2) 
deficient in the Golgi CMP-sialic acid transporter,  and 
therefore contained lactosylceramide as .the predomi- 
nant glycolipid. Acceptor Golgi apparatus  was pre- 
pared from another mutant,  Lec8, which is defective 
in UDP-Gal transport.  Thus,  glucosylceramide is the 
major glycolipid in Lec8 cells. Transport  was mea- 
sured by the incorporation of labeled sialic acid into 
lactosylceramide (present originally  in the donor) by 
transport to acceptor membranes,  forming GM3. This 
incorporation was dependent on ATP, cytosolic com- 
ponents,  intact membranes,  and elevated temperature. 
Donor membranes were prepared from Lec2 cells in- 
fected with vesicular stomatitus virus (VSV).  These 
membranes therefore contain the VSV membrane gly- 
coprotein,  G protein.  Donor membranes derived from 
VSV-infected cells could then be used to monitor both 
glycolipid and glycoprotein transport.  Transport of 
these two types of molecules between Golgi compart- 
ments was compared biochemically and kinetically. 
Glycolipid transport required the N-ethylmaleimide 
sensitive factor previously shown to act in glycopro- 
tein transport (Glick, B.  S., and J.  E.  Rothman.  1987. 
Nature [Lond.].  326:309-312;  Rothman,  J.  E.  1987. 
£  Biol.  Chem.  262:12502-12510).  GTPTS inhibited 
glycolipid and glycoprotein transport similarly.  The ki- 
netics of transport of glycolipid and glycoprotein were 
also compared.  The kinetics of transport to the end 
of the pathway were similar,  as were the kinetics of 
movement into a defined transport intermediate.  It is 
concluded that glycolipid and glycoprotein transport 
through the Golgi occur by similar if not identical 
mechanisms. 
T 
HE mechanisms that transport lipids between intracel- 
lular  organelles  are not well understood.  This con- 
trasts to the detailed picture that is emerging for protein 
trafficking.  This difference is partly because the distribution 
of lipids among intracellular  membranes does not generally 
show the absolute specificity that protein distribution does. 
Secondly,  the movement and functioning  of lipids is domi- 
nated  by subtle physical/chemical  properties,  such as acyl 
chain mobility,  and not by the sequence specificity that can 
be imparted by an amino acid chain.  The distribution  of 
lipids in membrane biogenesis has been covered recently in 
several  excellent  reviews  (Sleight,  1987; Bishop and Bell, 
1988; van Meet,  1989). 
Some lipids,  in particular phospholipids,  may be trans- 
ported by monomeric diffusion facilitated  by exchange pro- 
teins.  Phosphatidylethanolamine  and  phosphatidylcholine 
are in large part transported from their site of synthesis  in 
the ER to the plasma membrane without an appreciable lag 
time (Sleight and Pagano,  1983; Kaplan and Simoni,  1985a) 
and independent of cellular energy. On the other hand, the 
characteristics  of cholesterol and sphingolipid  transport are 
consistent with a vesicular mechanism.  For both, there is a 
marked lag time after synthesis  before they appear at the 
plasma  membrane  (Miller-Podraza  and  Fishman,  1982; 
DeGrella and  Simoni,  1982;  Lange  and  Matthies,  1984; 
Kaplan and Simoni,  1985b).  Cholesterol transport is sensi- 
tive to inhibitors  of metabolic energy production (DeGrella 
and Simoni,  1982; Kaplan and Simoni,  1985b). This energy 
requirement  has  not  been  demonstrated  for  sphingolipid 
movement. The involvement of the Golgi apparatus in sphin- 
golipid  transport was demonstrated in an elegant  series of 
studies by Pagano and associates using fluorescent analogues 
of ceramide that are incorporated into sphingomyelin  and 
glucosylceramide (Lipsky and Pagano,  1983;  Lipsky and 
Pagano,  1985). 
Sphingolipids  are a particularly interesting  group of lipid 
molecules.  They exhibit a very tight transmembrane asym- 
metry; they are mostly if not exclusively, found on the exo- 
plasmic surface (i.e., lumenal  in the Golgi) (for review, see 
Op den Kamp, 1979; van Meer, 1989). This is a consequence 
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transfer choline or sugars to ceramide to form sphingomyelin 
and glycolipids respectively (Lipsky and Pagano, 1985; and 
references therein; Keenan et al., 1974). There is apparently 
little or no flip/flop of these molecules between leaflets.  The 
bulk of gangliosides are  found on the plasma membrane 
(Miller-Podraza et al., 1982). Moreover, in polarized epithe- 
lia both sphingomyelin and glycosphingolipids are concen- 
trated into the apical membrane domain (van Meer and Si- 
mons,  1986;  and  references  therein).  The  ability  to  be 
targeted in this way may be related to the physical properties 
of these  lipids.  They  can  form  intermolecular hydrogen 
bonds (Pascher, 1976),  which can result in the formation of 
sphingolipid aggregates (Rintoul et al.,  1979).  In addition, 
sphingolipids exhibit a very high affinity for cholesterol (de 
Kruyff et al.,  1973).  Because of these properties,  sphin- 
golipids have been implicated in targeting of both proteins 
(van Meer and Simons,  1986) and cholesterol (Wattenberg 
and Silbert,  1983) to the cell surface. 
The experimental evidence cited above, along with the lu- 
menal orientation of the molecules, strongly suggests that 
sphingolipids are transported by a vesicular mechanism. The 
simplest model would be transport via the carriers that bring 
proteins to the plasma membrane. This is incorporated into 
the "bulk flow" model of  transport (for review, see Pfeffer and 
Rothman, 1987). In such a system there is continuous vesicu- 
lar movement through the Golgi and on to the plasma mem- 
brane. These vesicles pinch off a nonselective sample of the 
membrane and transport it to the next organelle in the path- 
way. Only molecules that are selectively retained in an or- 
ganelle are excluded from the vesicles. 
The studies presented here address whether glycosphin- 
golipids and proteins are transported by the same mecha- 
nism. Glycoprotein transport through the Golgi has been ex- 
tensively studied using a  cell free system (for review,  see 
Pfeffer and Rothman, 1987; Goda and Pfeffer, 1989; Watten- 
berg, 1990).  This system uses glycosylation as a marker for 
transport from one Golgi compartment to the' next. Glyco- 
protein transport requires energy as well as proteins found 
on the Golgi membranes and in the cytosolic fraction (Balch 
et al.,  1984a).  One such protein is the N-ethylmaleimide 
sensitive factor (NSF),~ which acts after the attachment of 
transport vesicles to the target Golgi (Malhotra et al., 1988). 
It has been shown to participate in transport from the ER to 
the Golgi (Beckers et al.,  1989) through the medial (Glick 
and Rothman, 1987) and trans-Golgi (Rothman, 1987) com- 
partments and in endocytosis (Diaz et al.,  1989).  Further- 
more,  the  nonhydrolyzable GTP analogue GTPys blocks 
transport by inhibiting the fusion of transport vesicles with 
the target membrane (Melan~on et al.,  1987).  These diag- 
nostic features provide the means to compare the transport 
mechanisms of different molecules. 
Here I describe the formulation of a cell free assay for the 
transport of a glycolipid between Golgi compartments. This 
assay,  described  in  detail  in  Results,  marks  transport by 
using the sequential glycosylation  reactions that produce ma- 
ture glycosphingolipids in the Golgi. Except for the mole- 
cules being measured, it is identical to the assay for glyco- 
1.  Abbreviations  used  in  this paper:  Gin,  2,3  sialyl lactosylceramide; 
LCRI, low cytosol requiting intermediate; NEM, N-ethylmaleimide; NSE 
NEM sensitive factor; VSV, vesicular stomatitus virus. 
protein transport, therefore facilitating a direct comparison 
between the two. Using these systems, glycolipid and glyco- 
protein transport were found to be biochemically and kineti- 
cally similar. 
Materials and Methods 
Materials 
[3H]CMP-sialic acid (26 Ci/mMol) was from New England Nuclear (Bos- 
ton,  MA).  Triton X-100 was purchased from Sigma Chemical Co.  (St. 
Louis, MO). GTP3"S was from Boehringer Mannheim GmbH (Mannheim, 
FRG). Control IgM, myeloma TEPC 183, was from Bionetics (Charleston, 
NC). Lipid standards were from Sigma Chemical Co. Ascites fluid contain- 
ing a monoclonal antibody to vesicular stomatitis virus (VSV) G protein 
(clone 8G5) (Lefrancois and Lyles, 1982) was a gift from Dr. Leo Lefran- 
cois of this department. Polyclonal rabbit anti-mouse serum was obtained 
from Cappel Laboratories (Malvern, PA). ENHANCE was purchased from 
New England Nuclear. X-Omat AR film was from Kodak (Rochester, NY). 
Thin layer chromatography plates were purchased from E. Merck (Darm- 
stadt, FRG). C-18 Sep Pak cartridges were from Waters Associates (Mil- 
ford, MA). The purified NSF (Block et al., 1988) and antibody to that pro- 
tein were generous gifts of P. Weidman and J.  Rothman (Department of 
Molecular Biology,  Princeton, NJ).  All other materials were purchased 
from commercial sources and were of reagent grade. 
Cells and Virus 
Lec2 and Lec8 (American Type Culture Collection, Rockville, MD; Stan- 
ley and Siminovitch, 1977) were grown in monolayer culture in a modified 
MEM containing 10% FCS. Wild-type Chinese hamster ovary (CHO) cells 
were grown in suspension culture in the same medium. Infections of Lec2 
with VSV were performed as previously described (Balch et al., 1984a)  for 
clone 15B. Stocks of VSV (Indiana strain) were harvested from infected 
baby hamster kidney cells as described (Balch et al.,  1984a). 
Membranes and Cytosol 
Donor membranes were produced from either uninfected or VSV-infected 
Lec2 cells essentially as described (Balch and  Rothman,  1985)  using a 
stainless steel ball bearing homogenizer to produce homogenates. After en- 
richment of Golgi membranes by sucrose density centrifugation (Balch and 
Rothman, 1985), the typical protein concentration was 0.5-1 mg/ml. Accep- 
tor  membranes from uninfected Lec8 cells were produced in the same 
manner. 
Cytosol was derived either from wild-type CHO cells or Lee2 cells. 
Results from the two were indistinguishable. The method of preparation was 
the same as that reported previously (Balch et al.,  1984a).  Before use, 
cytosol samples were centrifuged for 30 min at top speed in an Airfuge 
(Beckman Instruments, Inc., Palo Alto, CA) and the supernatant was taken. 
Response to both cytosol and membranes was linear within the range 
used (data not shown). 
Assays for Glycolipid  and Glycoprotein Transport 
In a standard assay, the indicated amounts of donor and acceptor (usually 
10 #1 each), cytosol (usually 5 #1), were added to a reaction mixture con- 
taining assay buffer (25 mM Hepes/25 mM KC1/2.5  mM Mg-acetate, pH 
7.0), an ATP regenerating system (50 #M ATE 250 #MUTE 2 mM creatine 
phosphate, 7.3 IU/ml creatine phosphokinase) and the indicated levels of 
[3H]CMP-sialic acid, in a total volume of 50 #1. These conditions are simi- 
lar to those previously reported for glycoprotein transport to the medial 
Golgi (Balch et al., 1984a).  Typically,  incubations were performed for 2 h 
at 37°C before terminating the assays for analysis. 
Analysis of Transport Assays 
To measure the amount of [3H]sialic  acid incorporated into 2,3 sialyl lac- 
tosylceramide (GM3)50-#l  transport reactions were extracted three times 
with 0.3 ml of CHCl3:methanol (1:1). Insoluble material was pelleted be- 
tween extractions with a 3-min centrifugation at 12,000 rpm in a microfuge 
(Beckman Instruments, Inc.). The extract was dried down under vacuum 
in a Speed Vac (Savant Instruments, Inc., Hicksville, NY). To remove the 
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Figure 1.  The  assay for  intercompartmental glycolipid 
transport. Transport of lactosylceramide is measured be- 
tween donor and acceptor Golgi populations. Donor is 
from  Lec2,  a  glycosylation mutant lacking the  Golgi 
CMP-sialic acid transporter and therefore deficient in all 
sialylated glycoconjugates including the ganglioside GM3 
(ceramide-Glc-Gal-SA). The predominant glycolipid in 
these cells is therefore lactosylceramide (ceramide-Glc- 
Gal). Acceptor is from LecS, a mutant lacking the UDP- 
galactose transporter (Deutscher and Hirschberg, 1986). 
The major glycolipid in these cells is glucosylceramide, 
which is not a substrate for the sialyltransferase that con- 
verts  lactosylceramide  to  GM3. If lactosylceramide  is 
transported from donor to acceptor, it will be sialylated. 
Transport is quantitated in the assay by the inclusion of 
[3H]CMP sialic acid in the incubation and measurement 
of the incorporation of [3H]sialic acid into GM3. 
bulk of the unincorporated tritium, as well as to eliminate contaminants in- 
terfering  with thin layer chromatography, a  purification was performed 
using Sep Pak C-18 cartridges (Waters Associates). Cartridges were pre- 
washed with 5 ml of methanol, and then 5 ml of water. Samples were taken 
up in 1 ml of water with vigorous vortexing and applied to the cartridges. 
This was repeated. The cartridges were then washed with 5 ml of water, 
and the excess water was blown out with air. Gangliosides were eluted with 
5 ml of CHCla:MeOH (1:1). This eluate was dried under nitrogen at 37°C. 
Figure 2.  Under assay conditions, radioactivity is 
incorporated into chromatographically authentic 
GM3. 20 #1 each of donor and acceptor (•20  #g 
membrane protein),  10  /~1 of CHO  cell cytosol 
(~50  ~g  protein),  using  the  buffer  and  ATP 
regenerating system  described  in Materials  and 
Methods,  with 4/zCi  [3H]CMP sialic acid,  in a 
total volume of 200 #1 was incubated for 2  h  at 
37°C. The incubation  mixture was extracted as de- 
scribed in Materials and Methods and analyzed by 
two-dimensional  thin layer chromatography essen- 
tially as described by Tanno et al. (1988), except 
that the thin layer plates used were silica gel 60. 
The  first  dimension  was  developed  twice  in 
CHCI3/MeOH/0.2%  CaCI2 (65:35:8) and the sec- 
ond dimension in N-propanol/NH3OH (28 %)/I-I20 
(75:5:25).  As  internal standards 20  /zg  each  of 
GM3, GM1, GDta, and Gztb were also included in the 
radioactive sample spotted.  After developing the 
plate, it was sprayed with scintillant as described 
and autoradiographed for 7 d. The plate was then 
sprayed with 50% H2SO4 and heated at ll0°C for 
1 h for visualization of standards. The identity of 
the standards (dotted lines) was established by com- 
parison to each standard run separately under iden- 
tical conditions. Labeled arrows indicate the first 
and second dimensions of development. 
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spored onto thin layer plates (Silica gel 60, 20 cm) in the preconcentration 
zone. Plates were developed in CHCI3:MeOH:0.5% CaCI2 (55:45:10).  Af- 
ter development, plates were thoroughly dried and saturated by spraying 
with ENHANCE (New England Nuclear). These were then dried and vis- 
ualized by autoradiography. A lane containing glycolipid standards was rou- 
tinely included. This lane was cut off and visualized by spraying with 50% 
sulfuric acid and heating at ll0*C. Autoradiograms were used as templates 
to localize the labeled GM3 and the appropriate areas were scraped into 
scintillation vials and counted in 10 ml of Ready Safe (Beckman Instruments, 
Inc.). The labeled spots always co-migrated with the GM3 standard at an Rf 
of •0.47. 
Incorporation of [3H]sialic  acid into VSV G protein was determined by 
immunopreeipitation onto filters by a modification of the method previously 
described (Balch et al.,  1984a).  50 #1 of stop buffer (50 mM Tris/0.2 M 
NaCI/5 mM EDTA/I% Triton X-100/I%  NaCholate, pH 7.4) was added to 
a 50/~1 assay. To this was added 0.6/~1 of anti-G protein monoclonal 8G5 
(as ascites fluid)  and 7/~1 of rabbit anti-mouse antiserum. This was in- 
cubated for  15  min at 37"C before filtration as described (Balch et al., 
1984a). 
Results 
The Assay for Glycolipid Transport 
The assay for transport of glycolipid between donor and ac- 
ceptor Golgi populations uses glycosylation as a marker for 
transit (Fig. 1). The logic of the assay is borrowed from well 
developed cell free systems measuring glycoprotein trans- 
port (Balch and Rothman,  1984;  Rothman,  1987).  Donor 
membranes were prepared from Lec2, a CHO cell mutant 
deficient  in  the  Golgi  transporter  for  CMP-sialic  acid 
(Deutscher et al.,  1984).  Therefore, all glycoconjugates in 
these cells are lacking sialic acid. The major glycolipid in 
Lec2 cells is lactosylceramide (Stanley, 1980) instead of the 
ganglioside Gm (sialic acid 2,3-Gal-Glc-ceramide) that is 
produced in wild-type cells. Acceptor Golgi was prepared 
from Lec8, which lacks an active UDP-galactose transporter 
(Deutscher and Hirschberg, 1986). The major glycolipid in 
these cells is glucosylceramide (Stanley, 1980).  Thus, ac- 
ceptor has the machinery to sialylate lactosylceramide to 
Gin,  but produces  no GM3 because  it lacks  the proximal 
substrate  for  the  sialyltransferase.  If lactosylceramide is 
transported from donor to acceptor,  it will be  sialylated. 
This was measured by including [3H]CMP-sialic  acid in the 
assay, and then measuring the incorporation of radioactivity 
into Gin.  In a  standard assay,  donor and acceptor mem- 
branes are mixed with CHO cell cytosol in a buffer contain- 
ing CHO cell cytosol, an ATP  regenerating system, and 
[3H]CMP-sialic  acid.  After incubation (generally for 2  h) 
the mixture is extracted and the ganglioside Gm is isolated 
by thin layer chromatography. 
Although Fig. 1 depicts lactosylceramide traveling from a 
medial compartment in the donor Golgi to a trans segment 
in acceptor,  neither the compartment of origin of the lac- 
tosylceramide nor the location of the sialyltransferase have 
been determined. Currently, then, it can only be stated with 
certainty that transport is between Golgi populations; the 
precise locale of delivery awaits localization of the lactosyl- 
ceramide sialyltransferase. 
Routinely, analysis of the glycolipid transport assays was 
performed using one dimensional thin layer chromatogra- 
phy. However,  it was important to ensure that the spot that 
co-migrated with GM3 in one dimension was truly Gin. A 
transport reaction was carried out, extracted, and analyzed 
by two-dimensional thin layer chromatography. The autora- 
diogram shown in Fig. 2 illustrates that the labeled product 
of the reaction co-migrates exactly with Gin, and not with 
any other ganglioside. 
For some experiments, it was desirable to compare pre- 
cisely glycolipid and glycoprotein transport. To accomplish 
this, donor membranes were prepared from cells infected 
with VSV. These membranes therefore contained the VSV 
glycoprotein, G protein, lacking sialic acid. Transport of G 
protein from donor to acceptor could then be marked by the 
incorporation of [3H]sialic acid into G protein. The trans- 
port of G protein to the trans-Golgi apparatus in a cell free 
system has  been  previously described  and  characterized 
(Rothman,  1987).  Glycolipid and protein transport could 
therefore be  measured  in  identical  incubations:  only the 
post-assay analysis differed. Control experiments indicated 
that  glycolipid transport  was  similar  when  measured  in 
membranes  from  infected  or  uninfected cells  (data  not 
shown). 
Production of GM~ in Transport Assays 
Requires Donor, Acceptor, ATP, Cytosol, and 
Intact Membranes 
The experiments depicted in Fig. 3 illustrate that the labeling 
of Gm occurs only under conditions that are expected to 
support transport. No labeling occurs if either donor or ac- 
ceptor is omitted from the assay mix. ATP dependence is a 
hallmark of  transport, whereas the simple enzymatic conver- 
sion of lactosylceramide to Gm is not ATP dependent. If 
the ATP regenerating system is not present, labeled Gm is 
not detected. Gm labeling also requires the presence of a 
high molecular weight cytosolic fraction. Protein transport 
through the Golgi requires several cytosolic proteins (Balch 
et al., 1984a;  Wattenberg and Rothman, 1986). The cytosol 
requirement for GM3 labeling in vitro is therefore indicative 
that this is a transport coupled labeling. The addition of Tri- 
ton  X-100  to  disrupt  the  Golgi  membranes  completely 
eliminates Gm labeling. In disrupted membranes, both lac- 
tosylceramide and sialyltransferase would be exposed to the 
extralumenal milieu. Under these conditions no labeling is 
found, presumably because both enzyme and substrate are 
dilute. Thus, it is unlikely that labeling in the absence of de- 
tergent is similarly due to solubilized sialyltransferase acting 
on exposed lactosylceramide. Finally, no labeling was ob- 
served when assays were incubated on ice instead of at 37°C. 
This strict temperature dependence is also characteristic of 
vesicular transport. Together, this group of  experiments indi- 
cate that the labeling of Gm in this assay is an indicator of 
lactosylceramide transport from donor to acceptor. 
Glycolipid Transport Requires N-Ethylmaleimide 
Sensitive Factor (NSF) for Glycoprotein Transport 
NSF was isolated on the basis of its requirement in glycopro- 
rein transport through the Golgi (Glick and Rothrnan, 1987; 
Block et al.,  1988). A neutralizing monoclonal antibody to 
NSF was added to reactions measuring either glycolipid or 
glycoprotein transport (Fig. 4). Addition of  the anti-NSF an- 
tibody at 6 mg/ml inhibited both glycolipid and glycoprotein 
transport by ,~50 %. There seems to be a slight difference in 
the dose response of glycolipid and glycoprotein transport to 
the antibody. However, these differences may lie within the 
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Figure 3.  Incorporation  of [3H]sialic acid into Gm requires both 
donor and acceptor, cytosol, ATE intact membranes, and incuba- 
tion at elevated temperature. Complete incubations contained 10 #1 
each of donor and acceptor,  5 t~l of CHO cell cytosol,  1 #Ci of 
[3H]CMP sialic acid and buffer, and ATP regenerating system as 
described in Materials and Methods in a total volume of 50 t~l. In- 
cubations were for 2 h at 37°C before extraction and analysis by 
one-dimensional thin layer chromatography and liquid scintillation 
counting as described in Materials and Methods. Where indicated, 
the  following modifications  were made:  acceptor or donor were 
replaced  with equivalent volumes of 35%  (wt/vol) sucrose in 10 
mM Tris (pH 7.4); the ATP regenerating system (ATE UTP, crea- 
tine phosphokinase,  creatine phosphate) was omitted; cytosol was 
replaced with 25 mM Tris/50 mM KCI; Triton X-100 was added 
to a final concentration of 0.1%; the incubation was for 2 h on ice 










1  O0  ~o 
o  o-~.  I 
I  • 
1  4o  1 
20 
0  I  I  I  I  I 
0.00  O. 10  0.20  0.30  0.40  0.50 
Anti-NSF ontibody odded  (/zg/ossay) 
l~gure 4. Glycolipid  and glycoprotein  transport are similarly inhibited 
by antibody to NSE Both glycoprotein (open circles) and glycolipid 
(closed circles) transport  incubations contained  10/~1 each of ac- 
ceptor and VSV-infected donor, 5 ~1 of CHO cell cytosol, the ATP 
regenerating system, and a buffer consisting of 25 mM Hepes/2.5 
mM MgAc/25 mM KC1/40 mM NaC1 in 50 #1. Glycoprotein trans- 
port assays (open circles) contained 0.5/~Ci [3H]CMP sialic acid, 
whereas glycolipid assays (closed circles) contained twice as much 
radioactivity. Assays were incubated with the indicated amount of 
antibody against NSF (6.7 mg/ml in 20 mM Tris/150 mM NaC1/ 
1 mM EDTA) for 15 min on ice before initiating the assays for 
2 h at 37°C. The volumes of added antibody were compensated by 
the addition of buffer of the same composition.  Values are com- 
puted as the percentage of counts in incubations without antibody. 
Shown are the average of four experiments (+SD). Addition of con- 
trol antibody (myeloma TEPC183) at similar concentrations  had 
only marginal effect (data not shown). 
inherent error of the measurements. Control antibodies had 
no effect (data not shown).  Inhibition of transport was not 
complete with increased levels of antibody. It has been sug- 
gested that some NSF on the membranes is not accessible 
to the antibodies (P.  Weidman, personal communication). 
To test more directly for the dependence of transport on 
NSF, membrane bound NSF was inactivated by a mild treat- 
ment with NEM (Fig. 5). NEM treatment strongly inhibited 
activity. When purified NSF is added back to NEM-treated 
membranes, both glycolipid and glycoprotein transport ac- 
tivity are partially restored. Activity is restored by 26 % (rel- 
ative to the untreated control) over the activity remaining in 
the NEM-treated membranes when measuring protein trans- 
port, and 35 % when measuring glycolipid transport. It is not 
clear whether this difference is significant. The lack of com- 
plete recovery by NSF had been noted earlier (Glick and 
Rothman,  1987).  This indicates that there are other mem- 
brane  components  that  are  partially  inactivated  by  NEM 
treatment. 
Together, these two experiments establish that NSF is re- 
quired  for  glycolipid  transport  as  it  is  for  glycoprotein 
transport. 
GTP3,S Inhibits Glycolipid and Glycoprotein Transport 
Identically 
GTP3,S is known to inhibit protein transport reactions at a 
step after the attachment of transport vesicles to the acceptor 
membrane surface, but before the uncoating of the vesicles 
(Melan~on et al.,  1987).  The experiment shown in Fig.  6 
demonstrates that glycolipid transport is also inhibited by 
GTP~S. Furthermore, the degree of inhibition is identical to 
that seen with glycoprotein transport using the same mem- 
branes. The inhibition of transport by GTP~/S was previously 
shown to depend on a high cytosol to membrane ratio in the 
assays (Melan~on et al.,  1987).  Because in the assays pre- 
sented here this ratio could not be optimized for GTP~/S inhi- 
bition while maintaining a reasonable transport signal, the 
inhibition of transport by the nucleotide was not complete. 
Glycolipid and Glycoprotein Transport Follow Similar 
Kinetics 
If glycolipids and glycoproteins are being co-transported, 
they should follow the same kinetics of movement. To ex- 
plore this, transport reactions were begun and aliquots were 
removed at various times and analyzed for both glycolipid 
and glycoprotein transport (Fig. 7). This measured the rate 
ofmovement from the beginning to the end of the pathway. 
The time course for glycolipid and glycopmtein transport 
were similar. Both exhibited a lag time of •  25 min before 
a linear rate of transport was achieved. This is considerably 
longer than the 7-10 min lag time for glycoprotein transport 
to the medial Golgi complex (Balch et al.,  1984a; Balch et 
al., 1984b). It is also slightly longer than the lag time previ- 
ously reported for G protein delivery to the trans Golgi ap- 
paratus  (Rothman,  1987).  Transport is complete by ~120 
min; the half-time of transport was 50-70 min. There were 
slight differences in the  curves during  the linear phase of 
transport. 
The lag time measured in the transport experiment de- 
scribed above is due to the time required to fill all of the ki- 
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Figure 5.  NSF is required for both glycolipid and glycoprotein 
transport. Analysis of assays for glycolipid and glycoprotein trans- 
port were performed on identical incubations coritaining 10 #1 each 
of acceptor and VSV-infected donor, 5 /zl of CHO cell cytosol, 
1 #Ci of CMP-siatic acid and buffer, and the ATP regenerating sys- 
tem. Assays were incubated for 2 h at 37°C. For NEM treatment 
of membranes, donor and acceptor were incubated with 0.1 mM 
NEM for 15 min on ice and then 0.4 mM DTT was added. Control 
membranes were exposed to DTT before NEM addition. Where in- 
dicated, 14 ng of  purified NSF was added to the incubations. Values 
are reported as percentage of counts incorporated into incubations 
with untreated membranes. Error bars indicate the range of dupli- 
cates in a single experiment (protein transport) or standard deviation 
of four determinations in two experiments (glycolipid transport). 
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netic intermediates in the process (Balch et al., 1984b; Wat-  o 
tenberg et al., 1986). The similar lag time for glycolipid and  × 
glycoprotein transport indicates that the kinetics of populating 
transport intermediates is the same for these two molecules. 
This was tested more precisely by measuring entry into a 
specific transport intermediate.  Such an  intermediate has 
been characterized in protein transport to the medial Golgi,  o 
and is termed the low cytosol requiring intermediate (LCRI)  -~  ~3 
(Wattenberg et al., 1986; Malhotra et al., 1988). This inter- 
mediate is formed after transport vesicles have attached to  ._~ 
the target membranes, but before fusion. The diagnostic foa- 
l  ture of this intermediate is that its formation requires rela-  ~, 
tively high levels of cytosol, whereas the processing of the 
LCRI leading to fusion proceeds at fivefold lower levels of 
cytosol. This is because cytosolic factors required for forma- 
tion of the LCRI are different from those needed after its for- 
mation (Wattenberg and Rothman,  1986; Wattenberg et al., 
1990). 
The time course of entry of glycolipids and glycoproteins 
into the LCRI was measured in a dilution assay (Fig.  7). 
Transport reactions were incubated under standard condi- 
tions for the time t indicated on the abscissa.  At that time, 
an aliquot was removed and diluted fivefold with a reaction 
mix complete except for cytosol. This diluted aliquot was 
then incubated for 180-t minutes, to allow the molecules that 
had reached the LCRI to progress to the end of the pathway. 
Again, the kinetics of transport of glycolipids and glycopro- 
teins were very similar with only slight differences in the lin- 
ear phase.  Entry into this intermediate proceeds without a 
lag time. This indicates that the lag time observed in the stan- 
dard assay is due primarily to steps that come after the for- 
marion of the LCRI. Entry into the LCRI is complete after 
90 min; three-quarters of the time required for all glycolipid 
or glycoprotein to reach the very end of the pathway.  This 
contrasts to measurements of the same kinetic step in trans- 
port to the medial Golgi. In the latter case, entry into the 
LCRI is complete after only 30% of the time required for 
glycoprotein to completely transit the pathway (Wattenberg 
et al.,  1986). 
Discussion 
A pivotal technique in attaining a detailed understanding of 
transport through the secretory pathway is the reconstiturion 
of  transport in cell free systems. Described here is the recon- 
stitution of glycolipid transport.  This complements the al- 
ready well-characterized glycoprotein transport assay. Glyco- 
lipid transport through the Golgi is measured by a transport 
coupled glycosylation reaction. This is similar to the way in 
which glycoprotein transport is measured in a previously es- 
tablished cell free system (Balch et al., 1984a). The ATP and 
cytosol dependence of  the assay, and the detergent and NEM 
sensitivity of the  membranes  used,  ensure that the  assay 
measures vesicular transport and not simply enzymatic gly- 
cosylation of lactosylceramide in leaky membranes. Under 
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Figure 6.  GTPTS is similarly inhibitory for glycolipid and glyco- 
protein transport. Incubations for analysis of glycolipid (closed cir- 
cles, right ordinate) and glycoprotein (open circles, left ordinate) 
transport were performed identically with 5 #l each of acceptor and 
VSV-infected donor, 5 #l of CHO cell cytosol, 1 #Ci of [3H]CMP 
sialic acid, buffer, and the ATP regeneration system. GTP~/S was 
added to the indicated final concentrations. Assays were incubated 
for 2 h at 37°C. Shown are the mean of triplicate samples. 
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Figure 7. The time course of glycolipid and glycoprotein transport 
to the end of the transport pathway are similar. Incubations were 
initiated at t = 0, and 50-/zl aliquots were removed at each indicated 
time point and placed on dry ice.  At the conclusion  of the time 
course, all samples were thawed and analyzed for transport of either 
giycotipid (right ordinate,  solid circles) or VSV G protein (left or- 
dinate, open circles). Incubations contained, for each time point, 10 
/~i of acceptor and  10/zl of VSV-infected donor, 5 #1 of CHO cell 
cytosol, buffer and the ATP regenerating  system, and either  0.5 
(glycoprotein transport) or 1.0 (glycolipid transport)/~Ci  [3H]CMP 








20.  o 
._c 
~  15. 
10- 
~o  5" 
o_  I 
0 
I 
-  ....  7 =  ..... 
5'  '  '  0  ~  00  150  2SQ 
Time of Incubation before Dilution (minutes) 




6  ~ 
-4  r~ 
._c 
o 
0  m 
Figure 8. The kinetics of  transport into the LCRI is similar for glyco- 
protein and glycolipid. Measurement of entry into the LCRI is ac- 
complished in a two-step assay. In the first incubation, for each time 
point,  a mixture was made of 5 #l each of acceptor and VSV-in- 
fected donor,  buffer, and  the ATP regeneration  system,  1.25 /~l 
CHO cell cytosol, and 0.5 #Ci CMP-sialic acid in a volume of 25 
#1. After incubation for the indicated times, 25 #1 aliquots were re- 
moved and diluted into  100/~1 of incubation buffer with the ATP 
regenerating  system,  0.5  /zCi/25 #1 of CMP-sialic  acid,  and  10 
~d/25/4 of 35%  sucrose to balance the sucrose contained  in the 
membrane fractions. The diluted samples were then further incu- 
bated for 180-t minutes. Samples were then analyzed for glycolipid 
transport (right ordinate,  solid circles) or VSV G protein transport 
(left  ordinate,  open  circles).  Shown are the  mean of duplicates 
(+range). 
shown that glycosylation does not arise from the wholesale 
fusion of membranes, or from transfer of the glycosyltrans- 
ferase from acceptor  to  donor  (Braell et al.,  1984).  The 
sialyltransferase adding sialic acid to glycoproteins has been 
localized to the trans-Golgi complex of several (but not all) 
cell types (for review, see Paulson and Colley,  1989).  It is 
reasonably certain that the destination of the measured pro- 
tein transport is therefore the trans-Golgi complex. The lo- 
calization of the glycolipid sialyltransferase, however, is un- 
known. By analogy, it seems reasonable that the glycolipid 
sialyltransferase is similarly located in a trans compartment, 
but at present it can only be said that the observed transport 
is between Golgi compartments. 
A  simple calculation illustrates that this assay measures 
the  bulk  of glycolipid  transport,  and  not  a  minor  side- 
pathway. The concentration of ganglioside sialic acid in rat 
liver Golgi complex is 0.25 nmol/mg of protein (Matyas and 
Morr6, 1987). The concentration of viral spike glycoprotein 
(determined for the Semliki Forest virus spike glycoprotein 
in baby hamster kidney cells) in the Golgi apparatus is ml% 
(Griffiths et al., 1983); for VSV G protein (molecular mass, 
65,000 D) this translates to 0.15 nmol/mg. Therefore, nearly 
equivalent  amounts  of [3H]sialic  acid  should  be  incorpo- 
rated into GM3 and G protein. This was what was observed 
(Fig. 6-8). There was some variability in the relative incor- 
poration  of label into  the two molecules,  possibly due to 
differences  in  VSV  infection;  however,  incorporation  of 
sialic acid into GM3 was generally within twofold of the in- 
corporation into G protein. Considering that more than one 
sialic acid can be incorporated into the G protein oligosac- 
charide, this comparison can only underestimate the relative 
ratio of GM3 to G  protein transport. 
Having established a cell free assay for glycolipid trans- 
port, glycolipid, and glycoprotein transport could be directly 
compared biochemically and kinetically.  An  advantage of 
this system is that the same membranes can be used for both 
assays. Two biochemical parameters were measured, the de- 
pendence on NSF and inhibition by GTP3,S. The time course 
of movement to the end of the pathway, as well as transport 
into a defined transport intermediate (LCRI), was also deter- 
mined.  In each of these tests,  glycolipid and glycoprotein 
transport were very similar. The slight differences that were 
observed  could  well  fall  within  experimental  variability. 
These data strongly argue against any nonvesicular route for 
glycolipid transport,  such as diffusion through the aqueous 
space, or lateral diffusion in the membrane through bridges 
between Golgi compartments. 
In a comparative study of this kind, it is impossible to es- 
tablish with certainty that glycolipids and glycoproteins use 
exactly the same mechanism. This knowledge will await the 
isolation of transport vesicles that can be shown to carry both 
types of cargo. The similarity of biochemistry and kinetics 
reported  here,  however,  makes  such  a  shared  machinery 
seem likely. This fits well with the bulk flow model of trans- 
port. That two molecules, differing vastly in size and other 
physical properties, have similar requirements and kinetics 
of transport suggests that nonspecific samples of membrane 
are being transported through the pathway. 
The  indication  that glycolipid and  glycoprotein are  co- 
transported through the Golgi apparatus has interesting im- 
plications for lipid and protein sorting. It has been suggested 
that the self-aggregating properties of sphingolipids may be 
involved in the protein sorting that occurs upon exit from the 
Golgi apparatus in polarized epithelial  (van Meer and Si- 
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tein supports this possibility. The high affinity of cholesterol 
for sphingolipids  suggests that cholesterol might be trans- 
ported by the same vesicular mechanism. Movement of cho- 
lesterol to the cell surface follows kinetics that are similar 
to that of a bulk membrane marker and indicative of vesicu- 
lar  transport  (DeGrella  and  Simoni,  1982;  Kaplan  and 
Simoni,  1985b).  However,  Urbani  and  Simoni  (1990)  re- 
cently reported that cholesterol movement is not affected by 
Brefeldin A, an antibiotic known to disrupt Golgi function 
and  interfere with protein egress  from the ER.  It remains 
possible that cholesterol enters the vesicular pathway late in 
the Golgi complex, possibly at the site of sphingolipid syn- 
thesis. The ability to measure glycolipid transport  in a cell 
free system should make it possible to test some of these con- 
cepts. 
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